Abstract

P64-4 HER2-directed therapies beyond progression in a patient with recurrent HER2-positive mucinous ovarian carcinoma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call